| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |